2024
Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?
Fezzi S, Ding D, Mahfoud F, Huang J, Lansky A, Tu S, Wijns W. Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention? Nature Reviews Cardiology 2024, 21: 652-662. PMID: 38710772, DOI: 10.1038/s41569-024-01014-0.Peer-Reviewed Original ResearchPercutaneous coronary interventionOptimal revascularizationRisk of periprocedural myocardial infarctionCoronary interventionMyocardial infarctionStent-related eventsEfficacy of percutaneous coronary interventionCoronary artery diseasePeriprocedural myocardial infarctionAcute myocardial infarctionReperfusion of acute myocardial infarctionClinical successRevascularization outcomesArtery diseaseIncreased riskAngiographic guidancePercutaneous revascularizationRevascularizationPatientsIntracoronary imagingLincoffDiagnostic toolPhysiological assessment
2001
Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: Experience with the AngioJet catheter
Silva J, Ramee S, Cohen D, Carrozza J, Popma J, Lansky A, Dandreo K, Baim D, George B, McCormick D, Setum C, Kuntz R. Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: Experience with the AngioJet catheter. American Heart Journal 2001, 141: 353-359. PMID: 11231431, DOI: 10.1067/mhj.2001.112997.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionImmediate definitive treatmentMyocardial infarctionRheolytic thrombectomyDefinitive treatmentDistal embolizationBalloon angioplastyFinal TIMI 3 flowAngioJet rheolytic thrombectomySubsequent definitive treatmentHospital mortality rateTIMI 3 flowMajor adverse eventsThrombus-containing lesionsMechanical thrombectomy devicesEvident thrombusPercutaneous revascularizationAdverse eventsAdjunctive treatmentProcedural complicationsAngioJet catheterClinical outcomesCoronary flowProcedure successThrombectomy devices
2000
The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions
Holmes D, Lansky A, Kuntz R, Bell M, Buchbinder M, Fortuna R, O’Shaughnessy C, Popma J, Investigators F. The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions. The American Journal Of Cardiology 2000, 86: 1073-1079. PMID: 11074202, DOI: 10.1016/s0002-9149(00)01162-0.Peer-Reviewed Original ResearchConceptsStent minimal lumen diameterTarget vessel failureMinimal lumen diameterAngiographic restenosisPalmaz-SchatzLumen diameterPS stentEnd pointSignificant differencesAverage stent lengthBinary angiographic restenosisInfrequent adverse eventsPrimary end pointSecondary end pointsSmaller reference vesselsCoronary arterial lesionsNative coronary lesionsPrior bypass surgeryLong-term outcomesPalmaz-Schatz stentsPrior restenosisLesion revascularizationPercutaneous revascularizationBypass surgeryClinical restenosisPercutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes
Gruberg L, Dangas G, Mehran R, Hong M, Waksman R, Mintz G, Kent K, Pichard A, Satler L, Lansky A, Stone G, Leon M. Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. Journal Of The American College Of Cardiology 2000, 35: 944-948. PMID: 10732892, DOI: 10.1016/s0735-1097(99)00652-x.Peer-Reviewed Original ResearchConceptsInternal mammary artery graftMammary artery graftsIMA graftsPercutaneous revascularizationBalloon angioplastyArtery graftClinical outcomesProcedural successMyocardial infarctionOne-year clinical outcomesLong-term clinical outcomesQ-wave myocardial infarctionAlternative interventional techniquesLower TLR rateUrgent bypass surgeryHigh procedural successLong-term outcomesTreatment of stenosisLong-term resultsOne-year ratesHospital complicationsHospital outcomesTLR rateAnastomotic lesionsBypass surgery
1999
In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site
Gruberg L, Hong M, Mehran R, Mintz G, Kornowski R, Lansky A, Kent K, Pichard A, Satler L, Dangas G, Wu H, Stone G, Leon M. In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site. The American Journal Of Cardiology 1999, 84: 1381-1384. PMID: 10606108, DOI: 10.1016/s0002-9149(99)00580-9.Peer-Reviewed Original ResearchConceptsSaphenous vein graftsDistal anastomosis siteLong-term outcomesBalloon angioplastyAnastomosis siteQ-wave myocardial infarction rateStent deploymentBalloon angioplasty groupMajor ischemic complicationsBaseline clinical characteristicsTarget lesion revascularizationMyocardial infarction rateProcedural success rateLower restenosis rateLong-term resultsRole of stentsHigh rateAngioplasty groupLesion revascularizationHospital outcomesInfarction rateIschemic complicationsPercutaneous revascularizationRepeat revascularizationClinical characteristicsLow- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion
Teirstein P, Mann J, Cundey P, Schechter E, Jacobs W, Grines C, Stagaman D, Lansky A, Hultquist M, Kusnick B, Heuser R, Kleinert H, Popma J. Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. The American Journal Of Cardiology 1999, 83: 1623-1628. PMID: 10392865, DOI: 10.1016/s0002-9149(99)00163-0.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAnticoagulantsCerebral HemorrhageChronic DiseaseCoronary AngiographyCoronary DiseaseDose-Response Relationship, DrugFemaleGraft Occlusion, VascularHeparinHumansInfusions, IntravenousMaleMiddle AgedPlasminogen ActivatorsRecombinant ProteinsSaphenous VeinUrokinase-Type Plasminogen ActivatorConceptsSaphenous vein graftsR-UKStudy drugVein graftsMyocardial infarctionNon-Q-wave myocardial infarctionPrimary study end pointSaphenous vein graft occlusionHigh-dose armStudy end pointLife-threatening bleedingVein graft occlusionHigh-dose groupDuration of infusionRecombinant urokinaseAcceptable success rateIntracerebral bleedPercutaneous revascularizationFinal angiogramGraft occlusionRecanalization rateAngiographic analysisHuman kidney cellsAllergic reactionsLow dose